Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

Stopped early

Conditions studied: Breast Cancer

In brief

RATIONALE: A breath test that measures enzymes may be effective in identifying women in whom tamoxifen may not be effective. PURPOSE: This clinical trial is studying a breath test to see how well it works in women receiving tamoxifen for the prevention or treatment of breast cancer.

Key facts

Study ID

NCT00873366

Run by

Mayo Clinic

People needed

92

Starts

2009-05-01

Expected to finish

2015-09-23

Last updated by the study team

2018-01-23

Who can join

Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Mayo Clinic in Arizona — Scottsdale, Arizona, United States
• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.